Reliance Global Group Stock News

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction. Foghorn Therapeutics Inc. (NASDAQ: FHTX ) shares jumped 55% to close at $18.58. Loxo Oncology, an R&D group of Eli Lilly And Co (NYSE: LLY ), and Foghorn Therapeutics collaborated to create oncology medicines by applying Foghorn''s Gene Traffic Control platform. BELLUS Health Inc. (NASDAQ: BLU ) gained 48.2% to settle at $8.30 after the company announced topline data its Phase 2b SOOTHE trial of BLU-5937 in Refractory Chronic Cough. Petros Pharmaceuticals, Inc. (NASDAQ: PTPI ) surged 47.4% to close at $3.98 after gaining more than 14% on Friday. Energy Focus, Inc. (NASDAQ: EFOI ) gained 36.2% to close at $4.70. East Stone Acquisition Corporation (NASDAQ: ESSC ) jumped 31.4% to close at $18.40 after gaining over 8% on Friday. Puxin Limited (NYSE: NEW ) climbed 27.1% to settle at $0.41 after tumbling over 10% on Friday.

The stock market is down today but these penny stocks are rallying. The post 4 Top Penny Stocks To Watch With The Stock Market Down Today appeared first on Penny Stocks to Buy, Picks, News and Informa

The stock market is down today but these penny stocks are rallying. The post 4 Top Penny Stocks To Watch With The Stock Market Down Today appeared first on Penny Stocks to Buy, Picks, News and Informa

Platform Now Live in 12 States Representing a Combined Population of More Than 82 Million People

Platform Now Live in 12 States Representing a Combined Population of More Than 82 Million People

Reliance Global Group Inc (RELI) shares closed this week 25.7% higher than it did at the end of last week. The stock is currently down 55.5% year-to-date, down 55.5% over the past 12 months, and down 55.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 0.1%. Trading Activity Shares traded as high as $3.38 and as low as $1.83 this week.Trading volume this week was 88.2% lower than the 10-day average and 61.3% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -1123.3% The company's stock price performance over the past 12 months lags the peer average by -1017.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

In the last trading session, 19.27 million shares of the Reliance Global Group Inc. (NASDAQ:RELI) were traded, and its beta was -1.24. Most recently the companys share price was $2.11, and it changed around $0.08 or 3.94% from the last close, which brings the market valuation of the company to $23.48M. RELI currently trades at Lets Get Started On The Reliance Global Group Inc. (NASDAQ: RELI) Stock Forecast. Read More »

LAKEWOOD, NJ, Nov. 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Reliance Global Group, Inc. (Nasdaq: RELI; RELIW), which combines AI and cloud-based technologies with the personalized experie

5MinuteInsure.com is now live in 8 states across the U.S. with a combined population of over 65 million

5MinuteInsure.com is now live in 8 states across the U.S. with a combined population of over 65 million

Third New State This Week; Coverage Now Spans 7 States in the US

Coverage now spans 6 states with more states to follow

Coverage now spans 6 states with more states to follow

Follows successful launch in MI, AZ, IN & OH; accelerating rollout to additional states in the near term